BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial.
D001500:BCG Vaccine / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D008297:Male; D009163:Mycobacterium bovis / Q000276:immunology*; D009461:Neurologic Manifestations; D012882:Skin Tests
D001500:BCG Vaccine; D003520:Cyclophosphamide